Attorneys for the FTX founder have inquired about possibly administering extended-release ADHD medication to their client, citing his difficulties maintaining focus throughout the trial. In a letter dated Oct. 15, attorneys for Sam Bankman-Fried reached out to New York District…
Related Posts
Bybit adds TON staking with Tonstakers integration
Crypto exchange Bybit has announced the integration of Tonstakers to bring new staking opportunities to its users. This…
Bybit: Circle’s IPO success marks the start of crypto listing surge
Circle’s explosive IPO has set a new benchmark for crypto equity listings, but the real story may lie…
Deutsche Bank tests Ethereum-based platform to mitigate margin compression
German banking giant Deutsche Bank AG views blockchain technology as a means to mitigate margin compression. A new…